Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Must-Have Cooking Machine in Your Kitchen - 2When does Spotify Wrapped come out? The music streamer says 'soon.'
- 3Toyota Just Electrified a Pickup Legend, but It Won’t Be Cheap
- 4A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- 5FDA updates risk classification for voluntary shredded cheese recall
- German finance minister sees advantages of smartphones in schools
- NMG signs new graphite supply deal with Canadian Government
- How many ships have been attacked in the Gulf since start of Iran war?
- Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying.
- How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600
- Innospace's rocket crashes in first commercial launch in Brazil; shares tumble
